Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$9.96 - $12.36 $890,314 - $1.1 Million
89,389 Added 757.34%
101,192 $1.25 Million
Q3 2024

Nov 14, 2024

SELL
$6.7 - $12.45 $128,867 - $239,463
-19,234 Reduced 61.97%
11,803 $134,000
Q2 2024

Aug 14, 2024

SELL
$6.34 - $9.28 $107 - $157
-17 Reduced 0.05%
31,037 $221,000
Q1 2024

May 15, 2024

BUY
$5.86 - $8.79 $181,976 - $272,964
31,054 New
31,054 $208,000
Q2 2022

Aug 15, 2022

BUY
$11.63 - $21.55 $135,629 - $251,316
11,662 New
11,662 $178,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $776M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.